Cargando…

Patient assessment of an electronic device for subcutaneous self-injection of interferon β-1a for multiple sclerosis: an observational study in the UK and Ireland

BACKGROUND: Injectable disease-modifying drugs (DMDs) reduce the number of relapses and delay disability progression in patients with relapsing–remitting multiple sclerosis (RRMS). Regular self-injection can be stressful and impeded by MS symptoms. Auto-injection devices can simplify self-injection,...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Arcy, Caroline, Thomas, Del, Stoneman, Dee, Parkes, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269318/ https://www.ncbi.nlm.nih.gov/pubmed/22298944 http://dx.doi.org/10.2147/PPA.S26250

Ejemplares similares

An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device
por: Willis, Helen, et al.
Publicado: (2014)

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study
por: Boeru, Gabriel, et al.
Publicado: (2013)

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study
por: Devonshire, Virginia, et al.
Publicado: (2010)

Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland
por: Keaver, Laura, et al.
Publicado: (2013)

Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice
por: Syed, Mehmood, et al.
Publicado: (2014)

Correction: Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland
por: Keaver, Laura, et al.
Publicado: (2013)

Interferon-gamma-induced local leukocytoclastic vasculitis at the subcutaneous injection site
por: Wang, Fang, et al.
Publicado: (2016)

Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)
por: Pedersen, Elena Didenko, et al.
Publicado: (2018)

A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
por: Jaber, Amer, et al.
Publicado: (2008)

Pentair Ltd, UK/Ireland
Publicado: (2020)

Pentair Ltd, UK/Ireland
Publicado: (2020)

Pentair Ltd, UK/Ireland
Publicado: (2020)

Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
por: Cohen, Yehuda Z., et al.
Publicado: (2022)

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
por: Cohan, Stanley
Publicado: (2016)

Factors Associated With Medication Use Among Individuals Living With Multiple Sclerosis
por: Alphonsus, Khrisha B., et al.
Publicado: (2020)

Subcutaneous Injections
Publicado: (1871)

Is There an Association Between Social Support and Pain Among Individuals Living With Multiple Sclerosis?
por: Alphonsus, Khrisha B., et al.
Publicado: (2021)

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis
por: Edo Solsona, María Dolores, et al.
Publicado: (2017)

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis
por: Freedman, Mark S., et al.
Publicado: (2021)

Hirschsprung's disease in the UK and Ireland: incidence and anomalies
por: Bradnock, T J, et al.
Publicado: (2017)

Burnout amongst neurosurgical trainees in the UK and Ireland
por: Salloum, Nadia Liber, et al.
Publicado: (2021)

Saline Subcutaneous Injections
Publicado: (1890)

The Subcutaneous Injection of Quinine
Publicado: (1902)

The Subcutaneous Injection of Quinine
por: Moore, W. J.
Publicado: (1881)

The Subcutaneous Injection of Quinine
por: Cullen, P.
Publicado: (1871)

Subcutaneous Injections of Strychnine
Publicado: (1893)

Danger of Subcutaneous Injections
Publicado: (1865)

Danger of Subcutaneous Injections
Publicado: (1865)

Subcutaneous Injections of Iron
Publicado: (1891)

The Subcutaneous Injection of Ether
Publicado: (1882)

Trends of intrauterine device insertion and ‘Googling’ about intrauterine devices before and during the COVID-19 pandemic in Australia
por: D’Arcy, Sarah, et al.
Publicado: (2022)

Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey
por: Ross, Amy Perrin, et al.
Publicado: (2023)

On the Subcutaneous Injection of Blood, Infusion (Subcutaneous) and Intravenous Transfusion
por: Oehler,, et al.
Publicado: (1888)

The cascade of care for children and adolescents with HIV in the UK and Ireland, 2010 to 2016
por: Chappell, Elizabeth, et al.
Publicado: (2019)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Jankovic, Slobodan M
Publicado: (2010)

Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland
por: Järvinen, Elina, et al.
Publicado: (2019)

A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis
por: Tolley, Keith, et al.
Publicado: (2015)

Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study
por: Singer, Barry, et al.
Publicado: (2012)

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
por: Duong, Trinh, et al.
Publicado: (2014)

RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES
por: Armstrong, J. A., et al.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_65oruuk4klb5j3nntrju4mpf7l